|
|
|
|
||
Both Gordon and McLure left Resverlogix-Zenith in 2014. Why did they leave?Patents (Issued & Applied) https://app.box.com/s/3eh4waxr2h337x8gd1l51mu4kcb9qgrx https://www.linkedin.com/pub/kevin-mclure/45/64a/154?trk=pub-pbmap Discovery Research & Development Consulting Preclinical strategy & technical writing September 2014 – Present (9 months)|Calgary, Canada Area Provide preclinical strategic research project consulting and technical writing to biotech and pharmaceutical companies. - Therapeutic areas: Oncology, Cardiovascular, Immunology, Metabolic - Program leadership expertise: Epigenetics, Protein homeostasis, Inflammation, Autoimmune, Metabolism - Line management experience: Lead Discovery, Biology, Translational Medicine Senior Director of Translational Biology Zenith Epigenetics Corp June 2013 – August 2014 (1 year 3 months)|Calgary, Canada Area Program Leadership: Oncology; Autoimmune Line Management: Lead Discovery; Biology; Translational Medicine - directed Preclinical Biology including lead discovery, biomarker discovery, PD marker assay development & validation, and mechanism of action for Oncology & Autoimmune programs - directed biology program to move and support a small molecule from hit to lead to development candidate to successful IND - set research strategy to meet corporate objectives - presented science program at conferences and in partnering & BD discussions with VCs & pharma - established and oversaw collaborations with academia & CROs |
return to message board, top of board |
Msg # | Subject | Author | Recs | Date Posted |
25947 | Re: Both Gordon and McLure left Resverlogix-Zenith in 2014. Why did they leave? | Jkj193741 | 0 | 5/13/2015 11:39:03 PM |